176 related articles for article (PubMed ID: 2586713)
1. [Experimental analysis of intracerebral natural resistance against H-2+ and H-2- lymphomas grafted into the brain].
Yamasaki T; Kikuchi H; Yamashita J; Ljunggren HG; Karre K; Klein G
No Shinkei Geka; 1989 Aug; 17(8):717-23. PubMed ID: 2586713
[TBL] [Abstract][Full Text] [Related]
2. Afferent and efferent cellular interactions in natural resistance directed against MHC class I deficient tumor grafts.
Ljunggren HG; Ohlén C; Höglund P; Yamasaki T; Klein G; Kärre K
J Immunol; 1988 Jan; 140(2):671-8. PubMed ID: 3335786
[TBL] [Abstract][Full Text] [Related]
3. Experimental appraisal of the lack of antitumor natural killer cell-mediated immunosurveillance in response to lymphomas growing in the mouse brain.
Yamasaki T; Moritake K; Klein G
J Neurosurg; 2003 Mar; 98(3):599-606. PubMed ID: 12650434
[TBL] [Abstract][Full Text] [Related]
4. Origin and differentiation of natural killer cells. I. Characteristics of a transplantable NK cell precursor.
Hackett J; Bennett M; Kumar V
J Immunol; 1985 Jun; 134(6):3731-8. PubMed ID: 3989295
[TBL] [Abstract][Full Text] [Related]
5. H-2 antigen expression and sensitivity of BL6 melanoma cells to natural killer cell cytotoxicity.
Gorelik E; Gunji Y; Herberman RB
J Immunol; 1988 Mar; 140(6):2096-102. PubMed ID: 3126240
[TBL] [Abstract][Full Text] [Related]
6. H-2Kb antigen expression has no effect on natural killer susceptibility and tumorigenicity of a murine hepatoma.
Nishimura MI; Stroynowski I; Hood L; Ostrand-Rosenberg S
J Immunol; 1988 Dec; 141(12):4403-9. PubMed ID: 3264312
[TBL] [Abstract][Full Text] [Related]
7. YAC-1 MHC class I variants reveal an association between decreased NK sensitivity and increased H-2 expression after interferon treatment or in vivo passage.
Piontek GE; Taniguchi K; Ljunggren HG; Grönberg A; Kiessling R; Klein G; Kärre K
J Immunol; 1985 Dec; 135(6):4281-8. PubMed ID: 3905967
[TBL] [Abstract][Full Text] [Related]
8. Natural resistance against tumors grafted into the brain in association with histocompatibility-class-I-antigen expression.
Yamasaki T; Akiyama Y; Fukuda M; Kimura Y; Moritake K; Kikuchi H; Ljunggren HG; Kärre K; Klein G
Int J Cancer; 1996 Jul; 67(3):365-71. PubMed ID: 8707410
[TBL] [Abstract][Full Text] [Related]
9. Abrogation of graft-vs.-leukemia activity after depletion of CD3+ T cells in a murine model of MHC-matched peripheral blood progenitor cell transplantation (PBPCT).
Uharek L; Glass B; Zeis M; Dreger P; Steinmann J; Löffler H; Schmitz N
Exp Hematol; 1998 Feb; 26(2):93-9. PubMed ID: 9472798
[TBL] [Abstract][Full Text] [Related]
10. Transfection of beta 2-microglobulin restores IFN-mediated protection from natural killer cell lysis in YAC-1 lymphoma variants.
Ljunggren HG; Sturmhöfel K; Wolpert E; Hämmerling GJ; Kärre K
J Immunol; 1990 Jul; 145(1):380-6. PubMed ID: 2113557
[TBL] [Abstract][Full Text] [Related]
11. Properties and characterization of a rat spleen cell-derived factor that induces resistance to natural killer cell lysis in YAC lymphoma cells.
Saxena RK; Saxena QB; Adler WH
J Immunol; 1988 Sep; 141(5):1782-7. PubMed ID: 2457628
[TBL] [Abstract][Full Text] [Related]
12. Enhanced H-2 expression and T-cell-dependent rejection after intracerebral transplantation of the murine lymphoma YAC-1.
Yamasaki T; Ljunggren HG; Ohlén C; Klein G; Kärre K
Cell Immunol; 1989 May; 120(2):387-95. PubMed ID: 2785859
[TBL] [Abstract][Full Text] [Related]
13. [Molecular analysis of mouse major histocompatibility complex class I gene expression of tumors growing in the brain].
Yamasaki T; Kikuchi H; Yamashita J; Kärre K; Ljunggren HG; Klein G
No Shinkei Geka; 1989 Mar; 17(3):229-37. PubMed ID: 2505151
[TBL] [Abstract][Full Text] [Related]
14. [Experimental analysis of anti-tumor cytotoxic mechanism for hybrid resistance to mouse neuroblastoma].
Yamasaki T; Moritake K; Kikuchi H; Kärre K; Ljunggren HG; Klein G
No Shinkei Geka; 1990 Nov; 18(11):1015-22. PubMed ID: 2247194
[TBL] [Abstract][Full Text] [Related]
15. Antileukemia activity of a natural killer cell line against human leukemias.
Yan Y; Steinherz P; Klingemann HG; Dennig D; Childs BH; McGuirk J; O'Reilly RJ
Clin Cancer Res; 1998 Nov; 4(11):2859-68. PubMed ID: 9829753
[TBL] [Abstract][Full Text] [Related]
16. Modulation of sensitivity to natural killer cell lysis after in vitro explantation of a mouse lymphoma.
Becker S; Kiessling R; Lee N; Klein G
J Natl Cancer Inst; 1978 Dec; 61(6):1495-8. PubMed ID: 281556
[TBL] [Abstract][Full Text] [Related]
17. The effects of polyinosinic:polycytidylic acid (pI:C) on the graft-vs-host (GVH) reaction. II. Increased NK-mediated rejection on C57BL/6 lymphocytes by (C57BL/6 X A)F1 mice.
Peres A; Nestel FP; Seemayer TA; Lapp WS
J Immunol; 1986 Dec; 137(11):3420-7. PubMed ID: 3537120
[TBL] [Abstract][Full Text] [Related]
18. NK cells from human MHC class I (HLA-B) transgenic mice do not mediate hybrid resistance killing against parental nontransgenic cells.
Kung SK; Su RC; Graham JJ; Chamberlain JW; Miller RG
J Immunol; 1998 Jan; 160(2):674-80. PubMed ID: 9551902
[TBL] [Abstract][Full Text] [Related]
19. Purification and target cell range of in vivo elicited blast natural killer cells.
Biron CA; Pedersen KF; Welsh RM
J Immunol; 1986 Jul; 137(2):463-71. PubMed ID: 3722814
[TBL] [Abstract][Full Text] [Related]
20. Target cell expression of MHC antigens is not (always) a turn-off signal to natural killer cells.
Chervenak R; Wolcott RM
J Immunol; 1988 Jun; 140(11):3712-6. PubMed ID: 3259596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]